| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261662.1 |
Tanespimycin |
Kidney renal clear cell carcinoma |
0.026287289 |
Resistant |
| ENSG00000261662.1 |
Tanespimycin |
Colon adenocarcinoma |
0.041758143 |
Sensitive |
| ENSG00000261662.1 |
Tanespimycin |
Brain lower grade glioma |
0.012388285 |
Sensitive |
